SHINE SA, April 2021 This year one of the largest ever studies on the experiences of LGBTQA+ young people in Australia was released: Writing Themselves In 4. The Australian Research Centre in Sex, Health and Society (ARCSHS) at La Trobe University asked 6,418 LGBTQA+ people aged 14 to 21 about their experiences with education, homelessness, harassment, assault, mental health, community...
Writing Themselves In 4 report released: SA-specific and national
Australian Research Centre in Sex, Health and Society (ARCSHS) at La Trobe University, 2/2/21 This report describes South Australia-specific findings from Writing Themselves In 4: a national survey of health and wellbeing among LGBTQA+ young people in Australia. Writing Themselves In 4 involved an online survey of people living in Australia aged between 14 and 21 years who identified as LGBTIQA+...
Private Lives 3: Australia’s largest national survey of health and wellbeing of LGBTIQ people released
Australian Research Centre in Sex, Health and Society (ARCSHS) at La Trobe University, Friday 13th November 2020 Australia’s largest national survey of health and wellbeing of LGBTIQ people reveals that most feel accepted at work and by family, but more work needs to be done to improve health outcomes. The Private Lives 3 National Report was conducted by researchers at the Australian Research...
COVID-19 Impact and Response for Sex Workers
Scarlet Alliance, 2020 STATEMENT OF IMPACT Sex workers throughout Australia have been devastatingly hit by the impact of coronavirus. As a workforce, sex workers are predominantly a mixture of precarious workers and the self-employed, being independent contractors who work in or for sex industry businesses, or sole traders who work independently for themselves. As such sex workers are...
Nurse Practitioner (s100) Prescribing Change
Hepatitis Australia, 3 April 2020 Hepatitis Australia warmly welcomes recent changes to the Pharmaceutical Benefits Scheme (PBS) allowing authorised Nurse Practitioners to prescribe hepatitis B and hepatitis C medicines under the Highly Specialised Drugs (s100) Program. Both hepatitis B and hepatitis C are under-treated and without improvement in a range of areas Australia risks falling short of...
Coronavirus disease (COVID-19), HIV & hepatitis C: What you need to know
CATIE (Canada), 17 March 2020 An HIV-positive person on effective treatment is not expected to be at higher risk of becoming seriously ill with COVID-19 A person with untreated HIV or a low CD4+ cell count may be at higher risk of becoming seriously ill with COVID-19 People with HIV or hepatitis C are more likely to have other conditions that carry a greater risk of becoming seriously ill with...